id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3017-0030,FDA,FDA-2018-N-3017,"Prescription Drug-Use-Related Software; Establishment of a Public
Docket; Request for Comments; Reopening of Comment Period",Notice,Extension of Comment Period,2019-02-26T05:00:00Z,2019,2,2019-02-26T05:00:00Z,2019-04-30T03:59:59Z,2019-06-18T18:50:48Z,2019-03241,0,0,0900006483aa6ed9
FDA-2018-N-3017-0006,FDA,FDA-2018-N-3017,Request for Extension of Comment Period from Proteus,Other,Request for Extension,2019-02-01T05:00:00Z,2019,2,2019-02-01T05:00:00Z,,2019-02-01T16:43:08Z,,0,0,0900006483a1c5ed
FDA-2018-N-3017-0004,FDA,FDA-2018-N-3017,Request for Extension from Combination Products Coalition,Other,Request for Extension,2018-12-11T05:00:00Z,2018,12,2018-12-11T05:00:00Z,,2018-12-11T20:12:00Z,,0,0,0900006483935cb6
FDA-2018-N-3017-0005,FDA,FDA-2018-N-3017,Request for Extension from Pharmaceutical Research and Manufacturers of America (PhRMA) and Biotechnology Innovation Organization (BIO),Other,Request for Extension,2018-12-11T05:00:00Z,2018,12,2018-12-11T05:00:00Z,,2018-12-11T20:14:35Z,,0,0,0900006483947070
FDA-2018-N-3017-0001,FDA,FDA-2018-N-3017,Prescription Drug-Use-Related Software; Establishment of a Public Docket; Request for Comments,Notice,Request for Comments,2018-11-20T05:00:00Z,2018,11,2018-11-20T05:00:00Z,2019-04-30T03:59:59Z,2019-06-18T18:50:27Z,2018-25206,0,0,09000064838ec2c9